Company intelligence / Profile preview
AuraVax Therapeutics
Houston, Texas, United Statesauravax.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Preclinical in vivo animal data show that the NanoSTING technology can enhance the immune system to address infections by multiple respiratory viruses without evidence of adverse events. The company was preparing its first IND application and clinical studies as of early/mid‑2023. The intranasal vaccine candidate has demonstrated both mucosal and systemic immunity in preclinical models. No human clinical results reported yet.
- Therapeutic areas
- Infectious Diseases
- Modalities
- NanoparticleVaccineHost-directed therapeutic (HDT)Mucosal adjuvant (for vaccines)Immunotherapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Exclusive license agreement with Massachusetts General Hospital for intranasal vaccine and therapeutics platform IPAcademic collaboration with University of Houston
Beyond the preview
Go deeper on AuraVax Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AuraVax Therapeutics.